tradmap

GOVX Financials GeoVax Labs, Inc.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 6.4% per year over the past 5 years.
  • Operating margin has contracted, at -869.3% in the latest year.

Financial health

  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$28M -$12M $4M $0 2013 2014 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-17207% -8604% 0% 2013 2014 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-1508% -416% 676% 0% 2013 2014 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$25M -$13M $0 2013 2014 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $14M $28M 2013 2014 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$25M $5M $35M $0 2013 2014 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $2M -$21M 0.0% -869.3% -561.2% -338.5% -$22M $3M
2024 $4M -$25M 0.0% -635.8% -495.0% -306.4% -$25M $6M
2023 $0 -$26M -450.6% -279.7% -$25M $6M
2022 $81526 -$14M 0.0% -17207.5% -52.7% -44.7% -$19M $28M
2021 $385501 -$19M 0.0% -4862.7% -425.8% -157.4% -$11M $11M
2020 $2M -$3M 0.0% -154.5% -30.9% -28.5% -$3M $10M
2019 $1M -$2M 0.0% -201.8% 150.6% -505.6% -$1M $283341
2018 $963203 -$3M 0.0% -266.1% 250.4% -398.7% $259701
2017 $1M -$2M 0.0% -202.2% 675.9% -442.7% -$2M $312727
2016 $828918 -$3M 0.0% -394.9% -1361.1% -536.2% $454030
2015 -$3M -223.3% -202.0% -$3M $1M
2014 -$3M -238.5% -205.0% -$2M $1M
2014 -$28M -1427.9% -1273.3% -$20M $2M
2013 -$2M -90.4% -80.5% -$2M $3M
2013 -$26M -1508.3% -1334.8% -$18M $2M

Valuation over time

How the market has priced GOVX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 30.3 60.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is GOVX growing its revenue and profit?

Over the past 5 years, GeoVax Labs, Inc.'s revenue has grown 6.4% per year. These are computed facts, not advice.

How much debt does GOVX have?

As of FY2025, GeoVax Labs, Inc. reported — of total debt against $3M of cash.

What is GOVX's profit margin?

In FY2025, gross margin was —, operating margin -869.3%, and net margin -862.3%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.